Skip to main content
Fig. 5 | Egyptian Journal of Radiology and Nuclear Medicine

Fig. 5

From: Correlation between increased serum malondialdehyde and spectrum of cranial ultrasonography findings in hypoxic ischemic encephalopathy: could it be used as a predictor of disease severity?

Fig. 5

ROC curve for discrimination between Sarnat stage III and Sarnat stage I or II patients using serum MDA levels. Area under the curve was 0.942. Cut-off MDA levels was > 3.1 nmol/ml. Sensitivity of MDA in Sarnat stage III compared to stages II or I was 95.45% and specificity was 85%

Back to article page